Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells.

Leptin, which serves as a lipid-modulating hormone to control metabolic energy availability, is decreased in Alzheimer's disease (AD) patients, and serum levels are inversely correlated to severity of dementia. We have previously described the effects of leptin in reducing amyloid beta protein both in vitro and in vivo, and tau phosphorylation in vitro. Herein, we systematically investigated the signaling pathways activated by leptin, leading to these molecular endpoints, to better understand its mechanism of action. Inhibition of amyloid beta production and tau phosphorylation in leptin-treated human and/or rat neuronal cultures were both dependent on activation of AMP-activated protein kinase (AMPK). Direct stimulation of AMPK with the cell-permeable activator, 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR), replicated leptin's effects and conversely, Compound C, an inhibitor of AMPK, blocked leptin's action. The data implicate that AMPK is a key regulator of both AD-related pathways.

[1]  S. Uotani,et al.  Leptin activates AMP-activated protein kinase in hepatic cells via a JAK2-dependent pathway. , 2006, Biochemical and biophysical research communications.

[2]  F. Pi‐Sunyer,et al.  Obesity‐related leptin regulates Alzheimer's Aβ , 2004 .

[3]  M. Compton,et al.  Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues. , 1998, Biochemical and biophysical research communications.

[4]  M. Birnbaum,et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.

[5]  J. Ninomiya-Tsuji,et al.  AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart , 2005, Circulation research.

[6]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[7]  D. Gustafson.  Adiposity indices and dementia , 2006, The Lancet Neurology.

[8]  R. Jope,et al.  AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3. , 2006, Biochemical pharmacology.

[9]  W. Guida,et al.  Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity , 2007, Proceedings of the National Academy of Sciences.

[10]  E. Jéquier.  Leptin Signaling, Adiposity, and Energy Balance , 2002, Annals of the New York Academy of Sciences.

[11]  B. Viollet,et al.  Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. , 2007, Diabetes & metabolism.

[12]  Young-Bum Kim,et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.

[13]  J. Trojanowski,et al.  Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. , 2000, Molecular biology of the cell.

[14]  Shaomeng Wang,et al.  3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. , 2000, Journal of medicinal chemistry.

[15]  Kristine Yaffe,et al.  Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study , 2005, BMJ : British Medical Journal.

[16]  M. Maccoss,et al.  Pyrroles and other heterocycles as inhibitors of p38 kinase. , 1998, Bioorganic & medicinal chemistry letters.

[17]  Fei Ye,et al.  The Dipeptide H‐Trp‐Glu‐OH Shows Highly Antagonistic Activity against PPARγ: Bioassay with Molecular Modeling Simulation , 2006, Chembiochem : a European journal of chemical biology.

[18]  C. Rosano,et al.  Serum leptin level and cognition in the elderly: Findings from the Health ABC Study , 2009, Neurobiology of Aging.

[19]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[20]  T. Hanihara,et al.  Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy , 1995, Neuropathology and applied neurobiology.

[21]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[22]  M. Mesulam,et al.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. , 2003, Archives of neurology.

[23]  R. Cowburn,et al.  The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation. , 2004, Biochemical and biophysical research communications.

[24]  C. Masters,et al.  Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.

[25]  J. Harvey.  Leptin: a diverse regulator of neuronal function , 2007, Journal of neurochemistry.

[26]  E. Barrett-Connor,et al.  Central obesity and increased risk of dementia more than three decades later , 2008, Neurology.

[27]  Sarah Tomlin,et al.  Microtechnology: Laying it on thick , 1999, Nature.

[28]  I. Grundke‐Iqbal,et al.  Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Simon Lovestone,et al.  The GSK3 hypothesis of Alzheimer's disease , 2008, Journal of neurochemistry.

[30]  Gustavo Pedraza-Alva,et al.  Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation , 2008, Science.

[31]  K. Okkenhaug,et al.  Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. , 2006, Blood.

[32]  G. Ronnett,et al.  Developing a head for energy sensing: AMP‐activated protein kinase as a multifunctional metabolic sensor in the brain , 2006, The Journal of physiology.

[33]  Sunmin Park,et al.  Exercise Enhances Insulin and Leptin Signaling in the Cerebral Cortex and Hypothalamus during Dexamethasone-Induced Stress in Diabetic Rats , 2006, Neuroendocrinology.

[34]  Steven J. Greco,et al.  Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. , 2008, Biochemical and biophysical research communications.

[35]  I. Grundke‐Iqbal,et al.  Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration , 2007, The European journal of neuroscience.

[36]  S. O’Rahilly,et al.  PPARγ and human metabolic disease , 2006 .

[37]  M. Sastre,et al.  Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's disease , 2006, Progress in Neurobiology.

[38]  R. Alexander,et al.  Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. , 2004, American journal of physiology. Cell physiology.